Opioids for the treatment of arthritis pain

Bibliography

• Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 2013;339(6116):166-72
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013;369(5):448-57
   PubMed Web of Science ®Google Scholar
• Huscher D, Thiele K, Gromnica-Ihle E, et al. Dose-related patterns of glucocorticoid-induced side effects. Ann Rheum Dis 2009;68(7):1119-24
   PubMed Web of Science ®Google Scholar
• Trelle S, Reichenbach S, Wandel S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 2011;342:c7086
   PubMed Web of Science ®Google Scholar
• Fox DA. Kinase inhibition–a new approach to the treatment of rheumatoid arthritis. N Engl J Med 2012;367(6):565-7
   PubMedGoogle Scholar
• Singh JA, Furst DE, Bharat A, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64(5):625-39
   PubMed Web of Science ®Google Scholar
• Pierer M, Baerwald C. [Biological therapy for the treatment of rheumatic diseases]. Internist (Berl) 2008;49(8):938-46
   PubMedGoogle Scholar
• Albrecht K, Kruger K, Wollenhaupt J, et al. German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. Rheumatol Int 2013. [Epub ahed of print]
   PubMedGoogle Scholar
• Perrot S, Dieude P, Perocheau D, Allanore Y. Comparison of pain, pain burden, coping strategies, and attitudes between patients with systemic sclerosis and patients with rheumatoid Aarthritis: a cross-sectional study. Pain Med 2013
   PubMedGoogle Scholar
• Stein C. Peripheral mechanisms of opioid analgesia. Anesth Analg 1993;76:182-91
   PubMed Web of Science ®Google Scholar
• Stein C, Machelska H. Modulation of peripheral sensory neurons by the immune system: implications for pain therapy. Pharmacol Rev 2011;63:860-81
   PubMed Web of Science ®Google Scholar
• Stein C, Küchler S. Non-analgesic effects of opioids: peripheral opioid effects on inflammation and wound healing. Curr Pharm Des 2012;18(37):6053-69
   PubMedGoogle Scholar
• Schumacher MA, Basbaum AI, Way WL. Opioid analgesics and antagonists. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and clinical pharmacology. 11th ed. McGraw-Hill Medical, New York; 2009. p. 531-52
   Google Scholar
• Dohrenbusch R. Verlaufsdokumentation und Veränderungsdiagnostik in der Schmerztherapie. In: Wendler J, Baerwald C, editors. Rheuma und schmerz. UNI-MED Verlag; Bremen: 2004. p. 37-48
   Google Scholar
• Stein C, Reinecke H, Sorgatz H. Opioid use in chronic noncancer pain: guidelines revisited. Curr Opin Anaesthesiol 2010;23(5):598-601
   PubMed Web of Science ®Google Scholar
• Eriksen J, Sjogren P, Bruera E, et al. Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain 2006;125(1-2):172-9
   PubMed Web of Science ®Google Scholar
• Stein C, Küchler S. Targeting inflammation and wound healing by opioids. Trends Pharmacol Sci 2013;34(6):303-12
   PubMed Web of Science ®Google Scholar
• Lee YC. Effect and treatment of chronic pain in inflammatory arthritis. CurrRheumatol Rep 2013;15(1):300-0300
   Google Scholar
• ACR Pain Management Task Force. Report of the American College of Rheumatology Pain Management Task Force. Arthritis Care Res (Hoboken) 2010;62(5):590-9
   PubMedGoogle Scholar
• Wendler J. Therapie mit Opioiden. In: Wendler J, Baerwald C, editors. Rheuma und schmerz. UNI-MED Verlag; Bremen: 2004. p. 56-73
   Google Scholar
• Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004;22(2 Suppl 1):1-12
   PubMed Web of Science ®Google Scholar
• Minnock P, FitzGerald O, Bresnihan B. Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status. Rheumatology (Oxford) 2003;42(8):995-1000
   PubMed Web of Science ®Google Scholar
• Heiberg T, Kvien TK. Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum 2002;47(4):391-7
   PubMedGoogle Scholar
• Whittle SL, Richards BL, Husni E, Buchbinder R. Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database SystRev 2011(11):CD003113
   PubMedGoogle Scholar
• Grijalva CG, Chung CP, Stein CM, et al. Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population. Rheumatology (Oxford) 2008;47(7):1061-4
   PubMedGoogle Scholar
• Katz WA. Opioids for nonmalignant pain. RheumDis Clin North Am 2008;34(2):387-413
   PubMedGoogle Scholar
• Zhang W, Moskowitz RW, Nuki G, et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. OsteoarthritisCartilage 2008;16(2):137-62
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res(Hoboken) 2012;64(4):465-74
   PubMed Web of Science ®Google Scholar
• Nüesch E, Rutjes AW, Husni E, et al. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database SystRev 2009(4):CD003115
   PubMedGoogle Scholar
• Kavanagh S, Kwong WJ, Hammond GC, et al. Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain. Pain Med 2012;13(9):1110-20
   PubMed Web of Science ®Google Scholar
• Hutchinson K, Moreland AM, de C Williams AC, et al. Exploring beliefs and practice of opioid prescribing for persistent non-cancer pain by general practitioners. Eur J Pain 2007;11(1):93-8
   PubMedGoogle Scholar
• Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis ResTher 2005;7(5):R1046-R51
   Google Scholar
• Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med 2011;155(5):325-8
   PubMed Web of Science ®Google Scholar
• Bohnert AS, Valenstein M, Bair MJ, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305(13):1315-21
   PubMed Web of Science ®Google Scholar
• Paulozzi L, Baldwin G, Franklin G, et al. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Morbidity and Mortality Weekly Report 2012;61(1):10-13
   PubMedGoogle Scholar
• Schubert I, Ihle P, Sabatowski R. Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int 2013;110(4):45-51
   PubMed Web of Science ®Google Scholar
• Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. OsteoarthritisCartilage 2007;15(8):957-65
   PubMed Web of Science ®Google Scholar
• Radner H, Ramiro S, Buchbinder R, et al. Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidity. Cochrane Database SystRev 2012(1):CD008951
   PubMedGoogle Scholar
• Marks JL, Colebatch AN, Buchbinder R, Edwards CJ. Pain management for rheumatoid arthritis and cardiovascular or renal comorbidity. Cochrane Database SystRev 2011(10):CD008952
   PubMedGoogle Scholar
• Solomon DH, Rassen JA, Glynn RJ, et al. The comparative safety of analgesics in older adults with arthritis. ArchIntern Med 2010;170(22):1968-76
   Google Scholar
• Miller M, Sturmer T, Azrael D, et al. Opioid analgesics and the risk of fractures in older adults with arthritis. J Am GeriatrSoc 2011;59(3):430-8
   PubMed Web of Science ®Google Scholar
• Endres-Becker J, Heppenstall PA, Mousa SA, et al. Mu-opioid receptor activation modulates transient receptor potential vanilloid 1 (TRPV1) currents in sensory neurons in a model of inflammatory pain. Mol Pharmacol 2007;71(1):12-18
   PubMed Web of Science ®Google Scholar
• Spahn V, Fischer O, Endres-Becker J, et al. Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner. Pain 2013;154(4):598-608
   PubMed Web of Science ®Google Scholar
• Vetter I, Cheng W, Peiris M, et al. Rapid, opioid-sensitive mechanisms involved in transient receptor potential vanilloid 1 sensitization. J Biol Chem 2008;283(28):19540-50
   PubMedGoogle Scholar
• Moshourab R, Stein C. Fentanyl decreases discharges of C and A nociceptors to suprathreshold mechanical stimulation in chronic inflammation. J Neurophysiol 2012;108(10):2827-36
   PubMed Web of Science ®Google Scholar
• Nockemann D, Rouault M, Labuz D, et al. The K channel GIRK2 is both necessary and sufficient for peripheral opioid-mediated analgesia. EMBO Mol Med 2013;5(8):1263-77
   PubMed Web of Science ®Google Scholar
• Kalso E, Smith L, McQuay HJ, Moore RA. No pain, no gain: clinical excellence and scientific rigour - lessons learned from IA morphine. Pain 2002;98(3):269-75
   PubMedGoogle Scholar
• Stein C, Schäfer M, Machelska H. Attacking pain at its source: new perspectives on opioids. Nat Med 2003;9(8):1003-8
   PubMed Web of Science ®Google Scholar
• Vadivelu N, Mitra S, Hines RL. Peripheral opioid receptor agonists for analgesia: a comprehensive review. J Opioid Manag 2011;7(1):55-68
   PubMedGoogle Scholar
• Patwardhan AM, Berg KA, Akopain AN, et al. Bradykinin-induced functional competence and trafficking of the delta-opioid receptor in trigeminal nociceptors. J Neurosci 2005;25(39):8825-32
   PubMed Web of Science ®Google Scholar
• Pettinger L, Gigout S, Linley JE, Gamper N. Bradykinin controls pool size of sensory neurons expressing functional delta-opioid receptors. J Neurosci 2013;33(26):10762-71
   PubMedGoogle Scholar
• Cayla C, Labuz D, Machelska H, et al. Impaired nociception and peripheral opioid antinociception in mice lacking both kinin B1 and B2 receptors. Anesthesiology 2012;116(2):448-57
   PubMedGoogle Scholar
• Labuz D, Schmidt Y, Schreiter A, et al. Immune cell-derived opioids protect against neuropathic pain in mice. J Clin Invest 2009;119(2):278-86
   PubMedGoogle Scholar
• Stein C. Towards safer and more effective analgesia. Vet J 2013;196(1):6-7
   PubMedGoogle Scholar
• Rittner HL, Amasheh S, Moshourab R, et al. Modulation of tight junction proteins in the perineurium to facilitate peripheral opioid analgesia. Anesthesiology 2012;116(6):1323-34
   PubMedGoogle Scholar
• Zöllner C, Mousa SA, Fischer O, et al. Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain. J Clin Invest 2008;118(3):1065-73
   PubMed Web of Science ®Google Scholar
• Mousa SA, Straub RH, Schäfer M, Stein C. Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis. Ann Rheum Dis 2007;66(7):871-9
   PubMed Web of Science ®Google Scholar
• Busch-Dienstfertig M, Labuz D, Wolfram T, et al. JAK-STAT1/3-induced expression of signal sequence-encoding proopiomelanocortin mRNA in lymphocytes reduces inflammatory pain in rats. Mol Pain 2012;8:83
   PubMedGoogle Scholar
• Rittner HL, Hackel D, Voigt P, et al. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS Pathog 2009;5(4):e1000362
   PubMed Web of Science ®Google Scholar
• Stein C, Hassan AHS, Lehrberger K, et al. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4
   PubMed Web of Science ®Google Scholar
• Roques BP, Fournie-Zaluski MC, Wurm M. Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat Rev Drug Discov 2012;11(4):292-310
   PubMed Web of Science ®Google Scholar
• Schreiter A, Gore C, Labuz D, et al. Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue. FASEB J 2012;26(12):5161-71
   PubMed Web of Science ®Google Scholar
• Hua S, Cabot PJ. Targeted nanoparticles that mimic immune cells in pain control inducing analgesic and anti-inflammatory actions: a potential novel treatment of acute and chronic pain condition. Pain Physician 2013;16(3):E199-216
   PubMedGoogle Scholar
• Craft RM, Henley SR, Haaseth RC, et al. Opioid antinociception in a rat model of visceral pain: systemic versus local drug administration. J Pharmacol Exp Ther 1995;275(3):1535-42
   PubMed Web of Science ®Google Scholar
• Shannon HE, Lutz EA. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacology 2002;42(2):253-61
   PubMedGoogle Scholar
• Reichert JA, Daughters RS, Rivard R, Simone DA. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 2001;89(2-3):221-7
   PubMedGoogle Scholar
• Fürst S, Riba P, Friedmann T, et al. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J Pharmacol Exp Ther 2005;312(2):609-18
   PubMedGoogle Scholar
• Labuz D, Mousa SA, Schafer M, et al. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 2007;1160:30-8
   PubMed Web of Science ®Google Scholar
• Gaveriaux-Ruff C, Nozaki C, Nadal X, et al. Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia. Pain 2011;152:1238-48
   PubMedGoogle Scholar
• Weibel R, Reiss D, Karchewski L, et al. Mu opioid receptors on primary afferent Nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice. PLoS ONE 2013;8(9):e74706
   PubMed Web of Science ®Google Scholar
• Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 2003;55(1):1-20
   PubMed Web of Science ®Google Scholar
• Graham T, Grocott P, Probst S, et al. How are topical opioids used to manage painful cutaneous lesions in palliative care? A critical review. Pain 2013;154(10):1920-8
   PubMed Web of Science ®Google Scholar
• Picard PR, Tramer MR, McQuay HJ, Moore RA. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 1997;72(3):309-18
   PubMed Web of Science ®Google Scholar
• Dahan A, van Dorp E, Smith T, Yassen A. Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur J Pain 2008;12(4):403-11
   PubMed Web of Science ®Google Scholar
• Binning AR, Przesmycki K, Sowinski P, et al. A randomised controlled trial on the efficacy and side-effect profile (nausea/vomiting/sedation) of morphine-6-glucuronide versus morphine for post-operative pain relief after major abdominal surgery. Eur J Pain 2011;15(4):402-8
   PubMed Web of Science ®Google Scholar
• Brown DR, Goldberg LI. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 1985;24(3):181-91
   PubMed Web of Science ®Google Scholar
• Maldonado R, Valverde O, Turcaud S, et al. Antinociceptive response induced by mixed inhibitors of enkephalin catabolism in peripheral inflammation. Pain 1994;58(1):77-83
   PubMedGoogle Scholar
• Blätke MA, Meyer S, Stein C, Marwan W. Petri Net modeling via a modular and hierarchical approach applied to nociception. In: Chaouiya C, Heiner M, editors. International Workshop on Biological Processes & Petri Nets. 2010 Braga, Portugal: 2010. p. 131-43; ISBN: 978-972-8692-53-7
   Google Scholar
• Küchler S, Wolf NB, Heilmann S, et al. 3D-wound healing model: influence of morphine and solid lipid nanoparticles. J Biotechnol 2010;148(1):24-30
   PubMedGoogle Scholar
• Antonijevic I, Mousa SA, Schäfer M, Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 1995;15(1):165-72
   PubMed Web of Science ®Google Scholar
• Hackel D, Krug SM, Sauer RS, et al. Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A 2012;109(29):E2018-27
   PubMedGoogle Scholar
• Stein C. Opioids, sensory systems and chronic pain. Eur J Pharmacol 2013;716(1-3):179-87
   PubMedGoogle Scholar
• Baker DE. Loperamide: a pharmacological review. Rev Gastroenterol Disord 2007;7(Suppl 3):S11-18
   PubMedGoogle Scholar
• Philippe D, Dubuquoy L, Groux H, et al. Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 2003;111(9):1329-38
   PubMed Web of Science ®Google Scholar
• Straub RH, Wolff C, Fassold A, et al. Antiinflammatory role of endomorphins in osteoarthritis, rheumatoid arthritis, and adjuvant-induced polyarthritis. Arthritis Rheum 2008;58(2):456-66
   PubMedGoogle Scholar
• McDougall JJ, Baker CL, Hermann PM. Attenuation of knee joint inflammation by peripherally administered endomorphin-1. J Mol Neurosci 2004;22(1-2):125-37
   PubMedGoogle Scholar
• Denko CW, Gabriel P. Effects of peptide hormones in urate crystal inflammation. J Rheumatol 1985;12(5):971-5
   PubMedGoogle Scholar
• Poonawala T, Levay-Young BK, Hebbel RP, Gupta K. Opioids heal ischemic wounds in the rat. Wound Repair Regen 2005;13(2):165-74
   PubMedGoogle Scholar
• Rook JM, Hasan W, McCarson KE. Morphine-induced early delays in wound closure: Involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochem Pharmacol 2009;77(11):1747-55
   PubMedGoogle Scholar
• Rook JM, McCarson KE. Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release. Biochem Pharmacol 2007;74(5):752-7
   PubMedGoogle Scholar
• Binder W, Scott C, Walker JS. Involvement of substance P in the anti-inflammatory effects of the peripherally selective kappa-opioid asimadoline and the NK1 antagonist GR205171. Eur J Neurosci 1999;11(6):2065-72
   PubMedGoogle Scholar
• Machelska H, Pflüger M, Weber W, et al. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J Pharmacol Exp Ther 1999;290(1):354-61
   PubMed Web of Science ®Google Scholar
• Binder W, Machelska H, Mousa S, et al. Analgesic and antiinflammatory effects of two novel kappa-opioid peptides. Anesthesiology 2001;94(6):1034-44
   PubMed Web of Science ®Google Scholar